文献速递甲状腺与颈部外科围术期管理与 ERAS

基于甲状旁腺激素的算法减少全甲状腺切除术后并发症

Parathyroid hormone-based algorithm reduces complications after total thyroidectomy.
PubMed 文献 · Surgery · 2024-11-29

该研究纳入2017至2022年连续全甲状腺切除术患者,第一时期比较术后第1天血钙与术中甲状旁腺激素(PTH)对低钙血症的预测价值,并制定算法;第二时期测试基于术中PTH的算法。结果显示算法使症状性低钙血症从16%降至2.3%,再入院从2.7%降至0.01%,永久性甲状旁腺功能减退无显著差异。

要点

  • 术中全甲状腺切除后20分钟PTH<20 pg/mL者,术后常规口服钙和阿尔法骨化醇。
  • 该算法使症状性低钙血症从16%降至2.3%,再入院从2.7%降至0.01%。
  • 永久性甲状旁腺功能减退率在两时期无显著差异(1.3% vs 1%)。

核心结论

  • 基于术中全甲状腺切除后20分钟PTH水平的算法联合常规预防性口服钙/骨化三醇,可降低全甲状腺切除术后症状性低钙血症和再入院风险。

研究设计与样本

  • 研究纳入2017至2022年连续全甲状腺切除术患者,第一时期1965例(1548例女性,平均年龄51岁),第二时期1420例(1106例女性,平均年龄50岁)。
  • 第一时期比较术后第1天血钙与术中全甲状腺切除后20分钟PTH对症状性低钙血症的预测价值,并制定算法;第二时期测试该算法。
  • 低钙血症定义为血清钙<8.0 mg/dL,甲状旁腺功能减退定义为PTH<15 pg/mL。

主要发现

  • 第一时期314例(16%)发生症状性低钙血症,术后第1天血钙<8.0 mg/dL仅预测183例(58%),联合术中PTH预测301例(96%)(P < .001),单用术中PTH预测282例(90%)。
  • 永久性甲状旁腺功能减退20例(1%),术中PTH预测18/20(90%),术后第1天血钙预测8/20(40%)(P < .01)。
  • 两时期永久性甲状旁腺功能减退无显著差异(1.3% vs 1%)(P = .8)。

关键数值与推荐

  • 术中全甲状腺切除后20分钟PTH<20 pg/mL的患者,术后常规口服钙和阿尔法骨化醇。
  • 低钙血症定义为血清钙<8.0 mg/dL,甲状旁腺功能减退定义为PTH<15 pg/mL。

临床怎么用

  • 全甲状腺切除术后可测量术中20分钟PTH,对PTH<20 pg/mL者预防性口服钙和阿尔法骨化醇,以减少症状性低钙血症和再入院。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypocalcemia after total thyroidectomy is a frequent complication that can be predicted and best managed by the postoperative measurement of parathyroid hormone levels. METHODS: This study included consecutive patients who underwent total thyroidectomy between 2017 and 2022. Hypocalcemia was defined as serum calcium <8.0 mg/dL and hypoparathyroidism as parathyroid hormone <15 pg/mL. After comparing serum calcium levels on postoperative day 1 and intraoperative parathyroid hormone levels 20 minutes after total thyroidectomy in the first period, an algorithm involving routine postoperative oral calcium and alfacalcidol administration in patients with intraoperative parathyroid hormone levels 20 minutes after total thyroidectomy <20 pg/mL was developed and tested during the second period. The rates of symptomatic hypocalcemia, readmission for hypocalcemia, and permanent hypoparathyroidism were compared between the 2 periods. RESULTS: In the first period, 1,965 total thyroidectomies (1,548 women; mean age, 51 years) were performed, including 617 patients (31%) with central neck dissection for thyroid carcinoma. Of 314 patients (16%) who experienced symptomatic hypocalcemia, only 183 (58%) could be predicted using serum calcium levels on postoperative day 1 <8.0 mg/dL. This rate increased to 96% (301 patients) when using intraoperative parathyroid hormone levels 20 minutes after total thyroidectomy and serum calcium levels on postoperative day 1 (P < .001). Intraoperative parathyroid hormone levels 20 minutes after total thyroidectomy alone could predict symptomatic hypocalcemia in 90% (282) of patients. Hypoparathyroidism was permanent in 20 patients (1%), with a greater predictive value of intraoperative parathyroid hormone levels 20 minutes after total thyroidectomy over serum calcium levels on postoperative day 1 (18/20 [90%] vs 8/20 [40%], P < .01). Using the intraoperative parathyroid hormone levels 20 minutes after total thyroidectomy-based algorithm and preventive calcium supplementation in the second period of the study, 1,420 total thyroidectomies (1,106 women; mean age, 50 years) were performed, including 392 (28%) cases with central neck dissection for thyroid carcinoma. Only 2.3% (32) patients developed a symptomatic hypocalcemia compared with 16% during the first period (P < .001). Thirty-eight patients (2.7%) experienced readmission after total thyroidectomy before implementation of the supplementation protocol in our study compared with 2 patients (0.01%) after we began using the protocol (P < .001). There was no significant difference in permanent hypoparathyroidism between the 2 periods (1.3% vs 1%) (P = .8). CONCLUSIONS: The parathyroid hormone-based algorithm determined by intraoperative parathyroid hormone levels 20 minutes after total thyroidectomy and routine preventive administration of oral calcium/calcitriol reduced the risk of symptomatic hypocalcemia and readmission after total thyroidectomy.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Chereau N, Gaujoux S, Ghander C, et al. Parathyroid hormone-based algorithm reduces complications after total thyroidectomy. Surgery. 2024. PMID: 39613653. doi:10.1016/j.surg.2024.10.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。